Workflow
安图生物:亚太地区以化学发光产品销售为主,欧洲高端市场以微生物质谱检测为“敲门砖”

Core Insights - Antu Biotech held a performance briefing for the first half of 2025, highlighting significant growth in overseas markets [1] Overseas Business Performance - The company has successfully sold products to over 100 countries and regions globally, with a focus on Asia, Europe, the Middle East, Africa, and Latin America [1] - Key products for international promotion include chemiluminescence, mass spectrometry, and immunoassay systems, with rapid growth observed in Asia (India, Southeast Asia), Latin America, and Europe [1] - The Asia-Pacific region primarily drives sales through chemiluminescence products, while Europe focuses on mass spectrometry products [1] Market Contribution - Overseas sales from the Asian market contribute over 40% to the company's revenue and continue to grow rapidly [1] - The contribution from emerging markets in Latin America is increasing year by year [1] - In Europe, the high-end market is gradually increasing its market share using mass spectrometry as an entry point [1]